Literature DB >> 19093207

Exposure to both radiation and chemotherapy increases the risk of Barrett's and multilayered epithelium.

Helen M Shields1, Abram Recht, Helen H Wang.   

Abstract

The relationship between radiation and/or chemotherapy and the development of Barrett's and/or multilayered epithelium has not been investigated before. We ascertained a group of patients exposed to radiation and/or chemotherapy and an unexposed group to compare the prevalence rates of Barrett's epithelium and multilayered epithelium at the time of endoscopy in these two groups. Barrett's epithelium was found in ten of the 19 (53%) exposed patients, compared to eight of 38 (21%) unexposed subjects (P = 0.02). Six of 19 (32%) exposed patients had multilayered epithelium, compared to four of 38 (11%) unexposed subjects (P = 0.06). Twelve of the 19 exposed patients (63%) had either Barrett's or multilayered epithelium, in contrast to ten of 38 (26%) unexposed subjects (P = 0.01). Those with exposure to both chemotherapy and radiation had a significant increase in the risk for Barrett's and/or multilayered epithelium (P = 0.003). This study suggests a relationship between exposure to a combination of radiation and chemotherapy and the development of Barrett's and/or multilayered epithelium.

Entities:  

Mesh:

Year:  2008        PMID: 19093207     DOI: 10.1007/s10620-008-0619-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

Review 1.  Side effects of adjuvant treatment of breast cancer.

Authors:  C L Shapiro; A Recht
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

Review 2.  Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach.

Authors:  Rhonda F Souza; Stuart J Spechler
Journal:  CA Cancer J Clin       Date:  2005 Nov-Dec       Impact factor: 508.702

3.  Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinoma.

Authors:  Melissa P Upton; Norman S Nishioka; Bernard J Ransil; Stanley J Rosenberg; William P Puricelli; Felice R Zwas; Helen M Shields
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

4.  Endoscopy in patients receiving radiation therapy to the thorax.

Authors:  Rodney A Perez; Dayna S Early
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

5.  Is chemotherapy associated with development of Barrett's esophagus?

Authors:  F T Peters; D T Sleijfer; G W van Imhoff; J H Kleibeuker
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

6.  Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study.

Authors:  Lesley A Anderson; R G Peter Watson; Seamus J Murphy; Brian T Johnston; Harry Comber; Jim Mc Guigan; John V Reynolds; Liam J Murray
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

7.  Radiation associated malignancies of the esophagus.

Authors:  D J Sherrill; B A Grishkin; F S Galal; R Zajtchuk; G M Graeber
Journal:  Cancer       Date:  1984-08-15       Impact factor: 6.860

8.  Second cancer risk following Hodgkin's disease: a 20-year follow-up study.

Authors:  F E van Leeuwen; W J Klokman; A Hagenbeek; R Noyon; A W van den Belt-Dusebout; E H van Kerkhoff; P van Heerde; R Somers
Journal:  J Clin Oncol       Date:  1994-02       Impact factor: 44.544

9.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus.

Authors:  Douglas A Corley; Ai Kubo; Theodore R Levin; Gladys Block; Laurel Habel; Wei Zhao; Pat Leighton; Charles Quesenberry; Greg J Rumore; Patricia A Buffler
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

Review 10.  The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.

Authors:  Richard M Logan; Andrea M Stringer; Joanne M Bowen; Ann S-J Yeoh; Rachel J Gibson; Stephen T Sonis; Dorothy M K Keefe
Journal:  Cancer Treat Rev       Date:  2007-05-15       Impact factor: 12.111

View more
  2 in total

1.  Personal and family history of cancer and the risk of Barrett's esophagus in men.

Authors:  N Khalaf; D Ramsey; J R Kramer; H B El-Serag
Journal:  Dis Esophagus       Date:  2014-02-17       Impact factor: 3.429

2.  Post-operative radiotherapy is beneficial for T1/T2 triple negative breast cancer patients with four or more positive lymph nodes.

Authors:  Lin Chen; Jinfeng Zhang; Jiayi Chen; Lili Liu; Lili Liang; Zhiyi Shangguan; Dandan Wang
Journal:  Oncotarget       Date:  2017-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.